Skip to main content
. 2022 Mar 21;49(7):517–525. doi: 10.1097/OLQ.0000000000001632

Figure 1.

Figure 1

Comparison in costs and QALYs of status quo (HepB vaccination with Heplisav) with the various prevaccination HBV testing strategies combined with vaccination among a cohort of 100,000 persons. The HBsAg + Vacc; HBsAg, anti-HBS + Vacc; and HBsAg, anti-HBS, anti-HBC + Vacc all are very closely overlapping. All have the same QALYs. See Figure 3 for a closer examination of the cost differences. Results for Engerix/Recombivax and Twinrix are similar and can be found in Appendix Table 4 (http://links.lww.com/OLQ/A809).